Dr. Amy Jenkins joined ARPA-H in March 2023 from the Defense Advanced Research Projects Agency (DARPA), where she was a Program Manager in the Biological Technologies Office. Her research interests include novel platforms for combating infectious diseases, as well as innovative manufacturing techniques capable of rapidly responding to a wide range of microbial threats. Prior to joining DARPA, Jenkins served as a senior scientist for Gryphon Technologies and as a researcher at MedImmune. Her work at that time focused on virulence factors and antibody targeting in multi-drug resistant pathogens. Jenkins earned a doctorate in chemistry and chemical biology from Cornell University and completed a National Research Council postdoctoral fellowship at the U.S. Army Medical Research Institute of Infectious Diseases.